Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
PurposeInsomnia is increasingly recognized as a major symptom outcome in breast cancer; however, little is known about its prevalence and risk factors among women receiving aromatase inhibitors (AIs), a standard treatment to increase disease-free survival among breast cancer patients.MethodsA cross-sectional survey study was conducted among postmenopausal women with stage 0–III breast cancer receiving adjuvant AI therapy at an outpatient breast oncology clinic of a large university hospital. The insomnia severity index (ISI) was used as the primary outcome. Multivariate logistic regression analyses were performed to evaluate risk factors.ResultsAmong 413 participants, 130 (31.5 %) had subthreshold insomnia on the ISI, and 77 (18.64 %) exceeded the threshold for clinically significant insomnia. In a multivariate logistic regression model, clinically significant insomnia was independently associated with severe joint pain (adjusted odds ratio (AOR) 4.84, 95 % confidence interval (CI) 1.71–13.69, P = 0.003), mild/moderate hot flashes (AOR 2.28, 95 % CI 1.13–4.60, P = 0.02), severe hot flashes (AOR 2.29, 95 % CI 1.23–6.81, P = 0.015), anxiety (AOR 1.99, 95 % CI 1.08–3.65, P = 0.027), and depression (AOR 3.57, 95 % CI 1.48–8.52, P = 0.004). Age (>65 vs. <55 years; AOR 2.31; 95 % CI 1.11–4.81; P = 0.026) and time since breast cancer diagnosis (<2 vs. 2–5 years; AOR 1.94; 95 % CI 1.02–3.69; P = 0.045) were also found to be significant risk factors. Clinical insomnia was more common among those who used medication for treating insomnia and pain.ConclusionsInsomnia complaints exceed 50 % among AI users. Clinically significant insomnia is highly associated with joint pain, hot flashes, anxiety and depression, age, and time since diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Bastien, C. (2001) · Sleep Medicine · doi:10.1016/s1389-9457(00)00065-4 · Cited by 8,067 · cited 1×
“The ISI has also been found to be a valid and sensitive measure to detect changes in perceived sleep difficulties following cognitive– behavioral or pharmacologic treatment for insomnia [27].”
BackgroundGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Prevalence of Sleep-disordered Breathing in Women
BIXLER, E. O., VGONTZAS, A. N., LIN, H.-M., TEN HAVE, T., REIN, J., VELA-BUENO, A., & KALES, A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.9911064 · Cited by 1,598 · cited 1×
“For example, research suggests that prevalence of sleep apnea, which may promote insomnia, is higher among postmenopausal women [36, 37].”
BackgroundMykletun, A., Stordal, E., & Dahl, A. A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.6.540 · Cited by 908
Insomnia in the Context of Cancer: A Review of a Neglected Problem
Savard, J., & Morin, C. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.895 · Cited by 861
Sleep disturbance in cancer patients
Davidson, J. R., MacLean, A. W., Brundage, M. D., & Schulze, K. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00043-0 · Cited by 661
Savard, M.-H., Savard, J., Simard, S., & Ivers, H. (2005) · Psycho-Oncology · doi:10.1002/pon.860 · Cited by 449
Prevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C. M. (2001) · SLEEP · doi:10.1093/sleep/24.5.583 · Cited by 414 · cited 2×
“A prior study conducted to evaluate the prevalence of insomnia among breast cancer patients found that 19 % of the participants met the diagnostic criteria for an insomnia syndrome [3], an estimate nearly identical to the clinically significant insomnia (18.”
BackgroundResultYoung, T., Rabago, D., Zgierska, A., Austin, D., & Finn, L. (2003) · SLEEP · doi:10.1093/sleep/26.6.667 · Cited by 371 · cited 1×
“For example, research suggests that prevalence of sleep apnea, which may promote insomnia, is higher among postmenopausal women [36, 37].”
Background
Cited by
Cramer, H., Lauche, R., Klose, P., Lange, S., Langhorst, J., & Dobos, G. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010802.pub2 · Cited by 441
Cognitive Behavioral Therapy in Persons with Comorbid Insomnia: A Meta-Analysis
Geiger-Brown, J. M., Rogers, V. E., Liu, W., Ludeman, E. M., Downton, K. D., & Diaz-Abad, M. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.11.007 · Cited by 331
Prevalence of sleep disturbance in patients with cancer: a systematic review and meta-analysis
Al Maqbali, M., Al Sinani, M., Alsayed, A., & Gleason, A. M. (2022) · Clinical Nursing Research · doi:10.1177/10547738221092146 · Cited by 167
Evaluation and management of insomnia in women with breast cancer
Kwak, A., Jacobs, J., Haggett, D., Jimenez, R., & Peppercorn, J. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05635-0 · Cited by 107
Matthews, E. E., Berger, A. M., Schmiege, S. J., Cook, P. F., McCarthy, M. S., Moore, C. M., & Aloia, M. S. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.41-03ap · Cited by 103
Metadata
- Authors
- Desai, K., Mao, J. J., Su, I., DeMichele, A., Li, Q., Xie, S. X., & Gehrman, P. R.
- Venue
- Supportive Care in Cancer
- Published
- 2012-05-15
- Volume
- 21
- Issue
- 1
- Pages
- 43-51
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2051445564
- Cited by
- 125
- References
- 11
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. https://app.cochat.ai/papers/10.1007/s00520-012-1490-z
- The paper
- Desai, K., Mao, J. J., Su, I., DeMichele, A., Li, Q., Xie, S. X., & Gehrman, P. R. (2013). Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Supportive Care in Cancer. https://doi.org/10.1007/s00520-012-1490-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.